Once again it was a boom year for merger & acquisition activity in medtech, with deals ranging in scale from a few million to $25 billion. In an era in which clinical differentiation and healthcare system efficiencies are must-haves, medtech companies used M&A to: 1) acquire product depth and breadth in one clinical sector, 2) find adjacencies that add value outside of the operating room and, 3) become partners with healthcare systems in reducing costs and improving outcomes. Here are 15 of the most noteworthy transactions:
Stradling represented Sequent Medical, Inc. in its merger with a U.S. subsidiary of Terumo Corporation, a global medical device company. Under the terms of the deal, Terumo acquired Sequent in an all-cash transaction for $380 million ($280 million up front and up to an additional $100 million if certain milestones are achieved). The transaction closed on July 13, 2016.